Updates sent to Twitter, March 1-7

Updates about CSC sent to Twitter during the first week of March:

Cancer stem cells in solid tumors: an overview, by O'Brien CA, Kreso A, Dick JE (Apr 2009) [March 7]: http://www.ncbi.nlm.nih.gov/pubmed/19249644

Brain tumors: New therapy surprisingly successful (March 06, 2009) [March 7]: http://tinyurl.com/c7exbm

Resistance to Endocrine Therapy: Are Breast Cancer Stem Cells the Culprits? [March 5]: http://www.ncbi.nlm.nih.gov/pubmed/19252972

Stem Cells Create Personalized Tumor in Mouse (about the niche dependency article by Katz, Skorecki & Tzukerman) [March 3]: http://tinyurl.com/czs52y

Variable niche dependency for the tumorigenic capacity of different cancer cell subpopulations [March 3]: http://www.ncbi.nlm.nih.gov/pubmed/19118034

First identification of cancer stem cells in Ewing's sarcoma family tumors (ESFT) [March 2]: http://www.ncbi.nlm.nih.gov/sites/entrez/19208848

Press release (24 Feb 2008) from Immunocellular Theraputics, about the CSC vaccine product candidate, ICT-121 [March 2]: http://tinyurl.com/demv6c

Cancer stem cells, hypoxia and metastasis, RP Hill et al. Semin Radiat Oncol 2009(Apr);19(2):106-11. Abstract [March 2]: http://tinyurl.com/dfxlop

Does eradication of CSC yield a successful therapeutic strategy? Question posed by RJ Jones & SA Armstrong [March 1] PMC: http://tinyurl.com/ccnnm6

[Page revised March 15, 2009]